Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Influenza

What does it mean if I get flu after the jab? Do COVID boosters increase the risk of side-effects? Key flu vaccine questions answered

The flu season has started early this year, and we are prepared for it to be a bad one. Whether you have already had a vaccine or are thinking about getting one, here are some answers to questions you may have.

The Conversation

Avian Flu Update: CFIA Reports Total of 16 Million Cases since 2022 — How to Spot Symptoms

The Canadian Food Inspection Agency confirms more than 16 million birds have been affected by avian flu since 2022. Here's what the virus is, where it has spread, and the symptoms farmers and owners should monitor.

International Business Times UK

Flu shots: how scientists around the world cooperate to choose the strains to vaccinate against each year

Twice a year, 40 scientists gather together for five days to decide what strains of influenza to vaccinate against for the next flu season. It takes around six months to prepare the vaccine – which usually includes protection against three different strains of flu. So in February, the group’s decision…

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

First human bird-flu death from H5N5 – what you need to know

H5N1 bird flu has infected growing numbers of people worldwide in recent years, but this week saw something new: the first recorded human case of an H5N5 avian influenza virus. What is this virus and how concerned about it should we be?

The Conversation

Christmas turkeys could be in short supply this year due to bird flu surge

Dozens of cases of avian influenza have been reported in the last two months, with free range and organic farms particularly affected

The Independent UK

Pfizer's New mRNA Flu Vaccine Outperforms Traditional Shot Against Predominant Strains

A Phase 3 study funded by Pfizer Inc. (NYSE:PFE) suggests that a nucleoside-modified messenger RNA influenza vaccine could offer stronger protection than traditional flu shots, marking a potential shift in how seasonal influenza is prevented.

Benzinga

Where are Europeans most and least likely to get the flu vaccine?

Immunisation rates were far below target levels in the last flu season, new data shows.

Euronews

Read news from The Economist, FT, and more,
with one subscription

Flu spreading ‘unusually early’ in Europe amid new strain, health officials warn

Health officials urge at-risk people to get vaccinated against influenza ‘without delay’.

Euronews

H5N1 bird flu cases spike in Europe. How worried should we be?

On November 13, Spain’s Ministry of Agriculture, Fisheries and Food imposed the confinement of all free-range poultry farms to curb the spread of avian influenza – more commonly known as “bird flu” – caused by the H5N1 virus. This drastic, though not unprecedented, measure was justified by climbing numbers of…

The Conversation

Merck Makes Big Bet On Flu Protection With Cidara Buyout

Merck Co. Inc. (NYSE:MRK) on Friday agreed to acquire Cidara Therapeutics, Inc. (NASDAQ:CDTX) for $221.50 per share in cash, for a total transaction value of approximately $9.2 billion.

Benzinga

Flu season has started early in the UK – here’s what might be going on

Flu season has got off to an early start this year in the UK – with cases spiking weeks earlier than in previous years. This has led to concerns that the UK may be on track for one of its worst flu seasons ever.

The Conversation

Pediatricians fill vaccine messaging void left by CDC amid bad flu season

Doctors step up after US health department suspended its flu vaccine campaign following Trump’s election

The Guardian - US

How we’re tracking avian flu’s toll on wildlife across North America

Since first being detected in Newfoundland in 2021, a subtype of highly pathogenic avian influenza, HPAI A(H5Nx), has had a dramatic impact on North America.

The Conversation

Force of nature: tributes flow for Labor giant 'Richo'

Graham "Richo" Richardson has died at 76, leaving behind a powerful legacy as a Labor powerbroker and environmental advocate.

AAP

Get all your
news in one place.

100's of premium titles.
One news app.

AAP

Flu deaths exceed COVID as vaccination rates plummet

Death data shows the flu is killing more people than COVID-19 for the first time since the height of the pandemic but experts fear deaths could get even higher.

Euronews

Bird flu virus has 'everything it takes to trigger a pandemic,' warns WHO virologist

"In principle, the H5N1 virus has everything it takes to trigger a pandemic," says virologist Klaus Stöhr in a report. Bird flu is currently spreading in Germany.

Euronews

Flu season is coming for Europe. How bad could it be this year?

It’s difficult to say just how severe the flu season will be before it starts. Here’s how experts try to predict it.

The Independent UK

Bird flu prevention zone to be introduced in Northern Ireland

It will place a legal requirement on all bird keepers to follow strict biosecurity measures

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

Avian influenza prevention zone to be introduced in NI

It will place a legal requirement on all bird keepers in the region to follow strict biosecurity measures.

AAP

Record-high flu season as jab rates stall, GPs warn

Stalling vaccination rates among children and seniors are exacerbating a record-breaking flu season, the peak body for general practitioners says.

International Business Times UK

Is COVID Back? Mystery Flu Outbreak in Asia Sparks Panic, Experts Reveal the Disturbing Truth

A surge in flu cases across Asia, hitting Japan weeks early, has sparked global alarm. Experts warn this unpredictable, year-round spread could be the new normal.

Benzinga

Cidara Therapeutics Analyst Says Lead Influenza Candidate Is 'Strategically Attractive'

JP Morgan initiated coverage of Cidara Therapeutics Inc. (NASDAQ:CDTX) on Friday, citing its lead asset, CD388, for influenza, underscoring the game-changing potential of the product and multi-billion dollar potential in the U.S. alone.

Benzinga

Cidara Therapeutics Surges Ahead of ESWI 2025 Presentation and JP Morgan Coverage

Cidara Therapeutics Inc (NASDAQ:CDTX) shares are trading higher on Friday after the biotech company made a recent announcement about their presentation at the upcoming ESWI 2025 conference. JP Morgan also initiated coverage of the stock, assigning it an Overweight rating and setting a price target of $200.

The Conversation

Flu season has arrived – and so have updated flu vaccines

As the autumn’s cool weather settles in, so does flu season – bringing with it the familiar experiences of sniffles, fever and cough.

Benzinga

Cidara Shares Are Trading Higher Friday: What's Going On?

Cidara Therapeutics, Inc. (NASDAQ:CDTX) shares are trading higher Friday after the company secured $339 million in BARDA funding to advance its CD388 pandemic influenza therapeutic and onshore its manufacturing.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

The Conversation Weekly

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.